Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older
- People who have been receiving care in a Nephrology (kidney) department since 2015
- People with cholangiocarcinoma (a type of cancer affecting the bile ducts) that has been confirmed through tissue or cell testing, at any stage of the disease
- People with hepatocellular carcinoma (a type of liver cancer) at any stage, where the cancer measures more than 1 cm, has developed on a scarred (cirrhotic) liver, and shows specific patterns on CT or MRI scans consistent with recognised diagnostic guidelines
- People with hepatocellular carcinoma that has been confirmed through tissue testing
Who may not be able to join:
- People who have not agreed to participate or who have objected to taking part in the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marie LEQUOY, MD, AssistancePublique-Hôpitaux de Paris
Phone: +330149283154
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Overall survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.